SCHEMBL6972025

SCHEMBL6972025

Fc1ccc(Cn2ccc(CN3CCC(c4ccccc4)(c4ccccc4)CC3)n2)cc1F

nearest known ligand 0.43

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
HTT P42858 1/20 0.42
SIGMAR1 Q99720 5/20 0.41
TMEM97 Q5BJF2 1/20 0.41
CACNA1G O43497 10/20 0.41
CACNA1H O95180 10/20 0.41
CACNA1I Q9P0X4 10/20 0.41
DRD4 P21917 1/20 0.38
CACNA1C Q13936 1/20 0.37
OPRL1 P41146 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6976215 0.99 ALDH1A1 (0.41) ALDH1A1HTTSIGMAR1TMEM97CACNA1G
SCHEMBL6975032 0.87 OPRD1 (0.42) ALDH1A1SIGMAR1OPRL1
Hydrochloric Acid SCHEMBL6980309 0.86 OPRD1 (0.41) ALDH1A1SIGMAR1OPRL1
SCHEMBL6976116 0.86 CCR3 (0.46) ALDH1A1SIGMAR1CACNA1GCACNA1HCACNA1I
SCHEMBL6976284 0.86 OPRL1 (0.48) ALDH1A1SIGMAR1OPRL1
Hydrochloric Acid SCHEMBL6971416 0.85 CCR3 (0.45) ALDH1A1SIGMAR1CACNA1GCACNA1HCACNA1I
SCHEMBL6973419 0.84 OPRL1 (0.53) HTTSIGMAR1OPRL1
SCHEMBL6969059 0.84 SIGMAR1 (0.51) ALDH1A1HTTSIGMAR1CACNA1GCACNA1H
SCHEMBL6968917 0.84 JAK2 (0.41) ALDH1A1HTTDRD4OPRL1
Hydrochloric Acid SCHEMBL6976568 0.83 OPRL1 (0.52) SIGMAR1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6566376-B1 For therapy of chemokine receptor related diseases and conditions such as rheumatoid arthritis, chronic obstructive pulmonary disease ASTRAZENECA UK LIMITED (GB) 2003-05-20 US claimed
EP-1202984-B1 DIPHENYL-PIPERIDINE DERIVATE ASTRAZENECA UK LTD (GB) 2003-03-05 EP claimed
US-6566376-B1 For therapy of chemokine receptor related diseases and conditions such as rheumatoid arthritis, chronic obstructive pulmonary disease ASTRAZENECA UK LIMITED (GB) 2003-05-20 US disclosed
EP-1202984-B1 DIPHENYL-PIPERIDINE DERIVATE ASTRAZENECA UK LTD (GB) 2003-03-05 EP disclosed